The Barbara Ann Karmanos Cancer Institute, a part of McLaren Health Care, has commenced the prescription of a new ...
Histotripsy is a new, FDA-approved, minimally invasive technique that destroys liver tumors using high-frequency ultrasound ...
A newly published review in eGastroenterology compiles recent research on alcohol-associated liver disease (ALD), offering an overview of its pathogenesis and efforts to better understand this ...
Bluejay Therapeutics, Inc., a clinical-stage biopharmaceutical company rapidly progressing transformative therapies for viral ...
Chronic liver damage can lead to hepatitis, which causes fibrosis of the liver. This buildup of collagen and other fibrous ...
Chronic liver damage can lead to hepatitis, which causes fibrosis of the liver. This buildup of collagen and other fibrous ...
A new device is now available for treating advanced liver cancer at home using electromagnetic waves, the Barbara Ann ...
RedePHine phase 1/2 clinical trial initiation expected in first half of 2025CAMBRIDGE, Mass., Dec. 19, 2024 (GLOBE NEWSWIRE) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback